Role of HER2-neu as a prognostic factor for survival and relapse in pT1a-bN0M0 breast cancer: a systematic review of the literature with a pooled-analysis.
about
Human epidermal growth factor receptor 2 and estrogen receptor status in respect to tumor characteristics in non-metastatic breast cancerFactors associated with the incidence of local recurrences of breast cancer in women who underwent conservative surgery.Chemotherapy use and surgical treatment by receptor subtype in node-negative T1a and T1b female breast cancers, Iowa SEER Registry, 2010 to 2012.For or against adjuvant trastuzumab for pT1a-bN0M0 breast cancer patients with HER2-positive tumors: a meta-analysis of published literatures.Overexpression of HER2/neu as a Prognostic Value in Iranian Women With Early Stage Breast Cancer; A Single Institute Study.Characteristics and clinical outcome of T1 breast cancer: a multicenter retrospective cohort study.The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer.Validity of whole slide images for scoring HER2 chromogenic in situ hybridisation in breast cancer.HER2 status in molecular apocrine breast cancer: associations with clinical, pathological, and molecular features.Her3 is associated with poor survival of gastric adenocarcinoma: Her3 promotes proliferation, survival and migration of human gastric cancer mediated by PI3K/AKT signaling pathway.Follow-up of Patients Treated for pT1aN0M0 Breast Cancer: 10-year Survival and Prognostic Factors.Nuclear expression of XBP1s is correlated with breast cancer survival: a retrospective analysis based on tissue microarray.Phosphorylation of NTRK1 at Y674/Y675 induced by TP53-dependent repression of PTPN6 expression: a potential novel prognostic marker for breast cancer.
P2860
Q34126938-A3FF8F04-47EF-4E79-B6A7-A10D8B3214FFQ34529914-512EF2A2-6FE4-4B41-B081-034D74F65A43Q34899436-89299702-4A41-4CB4-999F-3473F0E76931Q35083252-B1EFD4B0-C8ED-42EB-9AEE-D65D86F4C2C2Q35087728-BED56561-B129-4D78-B2C1-299DF91728F7Q35611839-74C410F1-A269-4AF5-A7E4-9E1665ADA187Q35764604-37B32F37-C987-4F6B-97A6-E750EF01050CQ36012823-E5DC26CF-E40E-421C-90D7-5FCBE66B89BEQ36014239-2F10098D-1ED0-4210-A698-668FB18EEAFCQ39016174-9F767AE8-D6B1-4DA9-B3D8-9ABFD3169EE6Q40877409-C8DF873B-2FEE-4E7D-A0EF-B08840F16402Q47096721-6C8F045E-9F2C-437F-BE13-BFEA23F9906CQ47772405-3082C654-964C-4CB5-ABED-664284DEB562
P2860
Role of HER2-neu as a prognostic factor for survival and relapse in pT1a-bN0M0 breast cancer: a systematic review of the literature with a pooled-analysis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Role of HER2-neu as a prognost ...... rature with a pooled-analysis.
@en
Role of HER2-neu as a prognost ...... rature with a pooled-analysis.
@nl
type
label
Role of HER2-neu as a prognost ...... rature with a pooled-analysis.
@en
Role of HER2-neu as a prognost ...... rature with a pooled-analysis.
@nl
prefLabel
Role of HER2-neu as a prognost ...... rature with a pooled-analysis.
@en
Role of HER2-neu as a prognost ...... rature with a pooled-analysis.
@nl
P2860
P1433
P1476
Role of HER2-neu as a prognost ...... rature with a pooled-analysis.
@en
P2093
P2860
P2888
P304
P356
10.1007/S12032-012-0201-4
P577
2012-03-14T00:00:00Z